Association between exhaled inflammatory markers and asthma control in children

D Van Vliet1, A Smolinska, Q Jöbsis

  • 1Department of Paediatric Pulmonology, School for Public Health and Primary Care (CAPHRI), Maastricht University Medical Centre (MUMC+), Maastricht, The Netherlands. Co-first authors.

Journal of Breath Research
|February 20, 2016
PubMed

Insights

This study found no link between general exhaled inflammatory markers and asthma control in children. However, specific volatile organic compounds (VOCs) effectively distinguished between well-controlled and poorly controlled asthma.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Biomarkers

Background:

  • Asthma control in children remains a challenge, with limited understanding of exhaled inflammatory markers.
  • Current methods for assessing asthma control may not fully capture disease status.
  • Investigating novel exhaled biomarkers is crucial for improving pediatric asthma management.

Purpose of the Study:

  • To determine the association between exhaled inflammatory markers (FeNO, VOCs, cytokines/chemokines) and asthma control in children.
  • To evaluate the ability of these markers to differentiate between persistently controlled and uncontrolled asthma.
  • To explore the utility of exhaled breath analysis in pediatric asthma phenotyping.

Main Methods:

  • A one-year observational study involving 96 asthmatic children.
  • Regular assessment of asthma control, fractional nitric oxide (FeNO), lung function (FEV1, FVC), exhaled VOCs, and EBC cytokines/chemokines.
  • Random Forest analysis and ROC-curve analysis for classification model evaluation.

Main Results:

  • No significant association was found between FeNO, EBC markers, or general VOCs and overall asthma control.
  • A panel of 15 exhaled VOCs demonstrated high accuracy (AUC 86%) in discriminating between persistently controlled and uncontrolled asthma.
  • Inclusion of FeNO and EBC markers did not significantly improve the classification accuracy of VOCs (AUC 87%).

Conclusions:

  • Exhaled inflammatory markers like FeNO and EBC cytokines/chemokines are not reliable indicators of asthma control in children.
  • Specific exhaled VOC profiles show promise as objective biomarkers for distinguishing asthma control states in pediatric populations.
  • VOC analysis may offer a non-invasive tool for identifying children with persistent uncontrolled asthma, aiding in personalized treatment strategies.

Related Concept Videos

Asthma-I: Introduction01:29

Asthma-I: Introduction

Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.7K
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.8K
Asthma-III: Symptoms and Complications01:24

Asthma-III: Symptoms and Complications

Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
3.6K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.7K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.3K
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
2.3K